Immunosuppresion
Conditions
Keywords
Wait-list control randomized trial
Brief summary
The goal of this wait-list control trial is to learn if having access to a new dashboard displaying information about immunosuppressed Veterans missing vaccinations for Shingrix can improve Shingrix vaccination rates at VA facilities. The main question\[s\] it aims to answer is: Will vaccination rates improve more rapidly for facilities with access to the dashboard compare to facilities without access? VA facility personnel will be granted access to the dashboard and outcomes (vaccination rates) will be measured using electronic health record data.
Detailed description
Assignment of the intervention will occur at the facility level. Outcomes (vaccination) will be assessed for patients cared for at each facility.
Interventions
OTHERAccess to Shingrix dashboard
The investigators will build and grant access to a clinical dashboard that exists behind the VA firewall. The dashboard will identify Veterans from each VA facility who are receiving immunosuppressants (prescribed via the VA). The dashboard will also provide information about the number of Shingrix vaccines each patient has received (which have been documented within the VA electronic health record). VA clinicians will have access to view information about patients based on their VA electronic health record permissions.
Sponsors
San Francisco Veterans Affairs Medical Center
University of California, San Francisco
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
The investigators will use a wait-list control design; clinicians from VA facilities will be randomized to receive access to the dashboard early vs. after a 6-9 month delay. The investigators will compare Shingrix vaccination rates in the two groups of facilities.
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* In order to be included in the study, clinicians need to work at a VHA facility and have access to the electronic health record.
Exclusion criteria
* None.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of patients with at least 1 Shingrix vaccine documented, by facility | From enrollment until end of follow up at 18 months. | Percentage of patients with at least 1 Shingrix vaccinations documented, by facility |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of patients with at least 2 Shingrix vaccinations documented, by facility | From enrollment until end of follow up at 18 months. | Percentage of patients with at least 2 Shingrix vaccinations documented, by facility |
Countries
United States
Outcome results
None listed